Learn More


 
MBA Tools
MBA Glossary

 


SPDR S&P Biotech (ETF) - XBI - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

SPDR S&P Biotech (ETF) - SIC # 6722

Ticker Exchange SIC # Website Latest Ticker
XBI New York 6722 https://www.spdrs.com/ 109.76 Stock Up +1.07

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for SPDR S&P Biotech (ETF)

Biotechnology ETF Investing 101 - May 20th, 2013 8:28 am
Positive Prognosis for Biotech ETFs - May 10th, 2013 12:10 pm
Investors Clamor for Generic Drug ETF - May 6th, 2013 2:20 pm
Beat Obamacare With These Biotech ETFs - Apr 22nd, 2013 1:30 pm
3 Sector ETFs Surviving This Slump - Apr 18th, 2013 11:17 am
3 Sector ETFs Surviving This Slump - Apr 18th, 2013 8:45 am
[video] FMHR Final Trade - Apr 16th, 2013 10:58 am
Playing To The Strengths Of Biotech - Apr 13th, 2013 7:26 am
Under The Hood: An Unheralded Biotech ETF - Apr 11th, 2013 12:55 pm
[video] Stock Pops & Drops - Apr 10th, 2013 3:46 pm
Buy, Sell, or Hold: Exelixis - Mar 20th, 2013 12:57 pm
XBI, ISIS, PCYC, INCY: ETF Inflow Alert - Mar 20th, 2013 8:55 am
Gilead Puts Biotech ETFs in Focus - Mar 11th, 2013 8:18 am


View All Current Headlines >>

Bookmark and Share
facebooktwitter